US Approves First Blood Test for Alzheimer’s Disease
The US Food and Drug Administration has approved the first blood test for Alzheimer’s disease, developed by Fujirebio Diagnostics. The test measures the ratio of two proteins in the blood, which is correlated with amyloid plaques in the brain. This breakthrough could help patients begin treatment earlier, using newly approved drugs that slow disease progression. … Read more